<code id='BEC51E0907'></code><style id='BEC51E0907'></style>
    • <acronym id='BEC51E0907'></acronym>
      <center id='BEC51E0907'><center id='BEC51E0907'><tfoot id='BEC51E0907'></tfoot></center><abbr id='BEC51E0907'><dir id='BEC51E0907'><tfoot id='BEC51E0907'></tfoot><noframes id='BEC51E0907'>

    • <optgroup id='BEC51E0907'><strike id='BEC51E0907'><sup id='BEC51E0907'></sup></strike><code id='BEC51E0907'></code></optgroup>
        1. <b id='BEC51E0907'><label id='BEC51E0907'><select id='BEC51E0907'><dt id='BEC51E0907'><span id='BEC51E0907'></span></dt></select></label></b><u id='BEC51E0907'></u>
          <i id='BEC51E0907'><strike id='BEC51E0907'><tt id='BEC51E0907'><pre id='BEC51E0907'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:389
          Beth Israel Deaconess Medical Center in Boston
          David L. Ryan/The Boston Globe

          Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry.

          While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.

          advertisement

          Industry leaders are calling for urgent action from the Healey administration and the Legislature to help stem the crisis. Even just simplifying the state regulatory bureaucracy and approvals for bringing uninsured patients into the MassHealth system would help, executives say.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Innovation in antibiotics is ailing. 'Brain drain' may kill it
          Innovation in antibiotics is ailing. 'Brain drain' may kill it

          Asantibioticsresearchshrivels,thebraindrainawayfromthisfieldwillhavemanylabslookingthisempty.AdobeIn

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          ASCO: AstraZeneca says CAR

          AdobeCHICAGO—Anext-generationCAR-Ttherapywasabletosubstantiallyshrinktumorsinpatientswithlivercancer